[go: up one dir, main page]

FI905683A0 - Menetelmä hidastetusti vapauttavan koostumuksen valmistamiseksi - Google Patents

Menetelmä hidastetusti vapauttavan koostumuksen valmistamiseksi

Info

Publication number
FI905683A0
FI905683A0 FI905683A FI905683A FI905683A0 FI 905683 A0 FI905683 A0 FI 905683A0 FI 905683 A FI905683 A FI 905683A FI 905683 A FI905683 A FI 905683A FI 905683 A0 FI905683 A0 FI 905683A0
Authority
FI
Finland
Prior art keywords
preparing
sustained release
release composition
devices
oral cavity
Prior art date
Application number
FI905683A
Other languages
English (en)
Swedish (sv)
Other versions
FI905683L (fi
FI98126B (fi
FI98126C (fi
Inventor
Nalinkant Chunilal Damani
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27031904&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=FI905683(A0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of FI905683A0 publication Critical patent/FI905683A0/fi
Publication of FI905683L publication Critical patent/FI905683L/fi
Publication of FI98126B publication Critical patent/FI98126B/fi
Application granted granted Critical
Publication of FI98126C publication Critical patent/FI98126C/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Inorganic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI905683A 1989-11-17 1990-11-16 Menetelmä hidastetusti vapauttavan koostumuksen valmistamiseksi FI98126C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US43906689A 1989-11-17 1989-11-17
US43906689 1989-11-17
US07/573,604 US5198220A (en) 1989-11-17 1990-08-24 Sustained release compositions for treating periodontal disease
US57360490 1990-08-24

Publications (4)

Publication Number Publication Date
FI905683A0 true FI905683A0 (fi) 1990-11-16
FI905683L FI905683L (fi) 1991-05-18
FI98126B FI98126B (fi) 1997-01-15
FI98126C FI98126C (fi) 1997-04-25

Family

ID=27031904

Family Applications (1)

Application Number Title Priority Date Filing Date
FI905683A FI98126C (fi) 1989-11-17 1990-11-16 Menetelmä hidastetusti vapauttavan koostumuksen valmistamiseksi

Country Status (14)

Country Link
US (1) US5198220A (fi)
EP (1) EP0430474B1 (fi)
JP (1) JP3051154B2 (fi)
KR (1) KR0156917B1 (fi)
AT (1) ATE118170T1 (fi)
AU (1) AU648278B2 (fi)
CA (1) CA2029046C (fi)
DE (1) DE69016755T2 (fi)
DK (1) DK0430474T3 (fi)
ES (1) ES2067696T3 (fi)
FI (1) FI98126C (fi)
GR (1) GR3015027T3 (fi)
IE (1) IE66371B1 (fi)
NZ (1) NZ236113A (fi)

Families Citing this family (95)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6309669B1 (en) * 1984-03-16 2001-10-30 The United States Of America As Represented By The Secretary Of The Army Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
US5487897A (en) * 1989-07-24 1996-01-30 Atrix Laboratories, Inc. Biodegradable implant precursor
US5324519A (en) * 1989-07-24 1994-06-28 Atrix Laboratories, Inc. Biodegradable polymer composition
AU2605592A (en) * 1991-10-15 1993-04-22 Atrix Laboratories, Inc. Polymeric compositions useful as controlled release implants
FR2691360B1 (fr) * 1992-05-20 1995-06-30 3P Agence Conseil Compositions pharmaceutiques destinees en particulier au traitement des poches parondontales et procede de fabrication.
NZ247712A (en) * 1992-06-19 1995-04-27 Colgate Palmolive Co Oral composition comprising an anti-bacterial compound, a water-insoluble biodegradable polymer, and an organic solvent
US5922340A (en) 1992-09-10 1999-07-13 Children's Medical Center Corporation High load formulations and methods for providing prolonged local anesthesia
US5242910A (en) * 1992-10-13 1993-09-07 The Procter & Gamble Company Sustained release compositions for treating periodontal disease
US6001895A (en) * 1993-03-22 1999-12-14 Johnson & Johnson Medical, Inc. Composite surgical material
GB2280850B (en) * 1993-07-28 1997-07-30 Johnson & Johnson Medical Absorbable composite materials for use in the treatment of periodontal disease
US6015844A (en) * 1993-03-22 2000-01-18 Johnson & Johnson Medical, Inc. Composite surgical material
US5447725A (en) * 1993-06-11 1995-09-05 The Procter & Gamble Company Methods for aiding periodontal tissue regeneration
EP0721324A1 (en) * 1993-10-01 1996-07-17 The Procter & Gamble Company Use of azithromycin for the treatment of adult periodontitis and topical compositions for this use
US5639466A (en) * 1994-02-24 1997-06-17 Chronopol, Inc. Method for packaging foodstuffs
US6068859A (en) 1994-05-06 2000-05-30 Pfizer Inc. Controlled-release dosage forms of Azithromycin
JPH08113534A (ja) * 1994-10-17 1996-05-07 Ichiro Umeuchi 歯周病治療器具
US5612052A (en) * 1995-04-13 1997-03-18 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
US6413539B1 (en) 1996-10-31 2002-07-02 Poly-Med, Inc. Hydrogel-forming, self-solvating absorbable polyester copolymers, and methods for use thereof
US6551610B2 (en) 1995-04-13 2003-04-22 Poly-Med, Inc. Multifaceted compositions for post-surgical adhesion prevention
DE69632569T2 (de) * 1995-06-09 2005-08-18 Euroceltique S.A. Formulierungen und verfahren für eine verlängerte lokalanästhesie
US5747060A (en) * 1996-03-26 1998-05-05 Euro-Celtique, S.A. Prolonged local anesthesia with colchicine
EP0954301A4 (en) 1996-06-24 2006-03-08 Euro Celtique Sa SAFE METHODS OF LOCAL ANESTHESIA
US6046187A (en) 1996-09-16 2000-04-04 Children's Medical Center Corporation Formulations and methods for providing prolonged local anesthesia
US20020111603A1 (en) 1996-12-02 2002-08-15 Societe De Conseils De Recherches Et D'application Device for local administration of solid or semi-solid formulations and delayed-release formulations for proposal parental administration and preparation process
CA2283830C (en) * 1997-03-18 2008-07-22 Sunstar Inc. Composition for forming solid particles
US5962006A (en) * 1997-06-17 1999-10-05 Atrix Laboratories, Inc. Polymer formulation for prevention of surgical adhesions
KR100367144B1 (ko) 1997-07-02 2003-01-14 유로-셀티크 소시에떼 아노뉨 관절과 체강(ｂｏｄｙ ｓｐａｃｅ)내에서 연장된 마취
US6846478B1 (en) 1998-02-27 2005-01-25 The Procter & Gamble Company Promoting whole body health
US7128927B1 (en) 1998-04-14 2006-10-31 Qlt Usa, Inc. Emulsions for in-situ delivery systems
US6245345B1 (en) 1998-07-07 2001-06-12 Atrix Laboratories, Inc. Filamentous porous films and methods for producing the same
US6605294B2 (en) * 1998-08-14 2003-08-12 Incept Llc Methods of using in situ hydration of hydrogel articles for sealing or augmentation of tissue or vessels
US6632457B1 (en) * 1998-08-14 2003-10-14 Incept Llc Composite hydrogel drug delivery systems
US6818018B1 (en) 1998-08-14 2004-11-16 Incept Llc In situ polymerizable hydrogels
US6179862B1 (en) 1998-08-14 2001-01-30 Incept Llc Methods and apparatus for in situ formation of hydrogels
US6514534B1 (en) * 1998-08-14 2003-02-04 Incept Llc Methods for forming regional tissue adherent barriers and drug delivery systems
CA2340381C (en) * 1998-08-14 2009-01-13 Incept Llc Methods and apparatus for in situ formation of hydrogels
US6152943A (en) * 1998-08-14 2000-11-28 Incept Llc Methods and apparatus for intraluminal deposition of hydrogels
US6143314A (en) * 1998-10-28 2000-11-07 Atrix Laboratories, Inc. Controlled release liquid delivery compositions with low initial drug burst
US6565874B1 (en) 1998-10-28 2003-05-20 Atrix Laboratories Polymeric delivery formulations of leuprolide with improved efficacy
US8226598B2 (en) 1999-09-24 2012-07-24 Tolmar Therapeutics, Inc. Coupling syringe system and methods for obtaining a mixed composition
US6626870B1 (en) 2000-03-27 2003-09-30 Artix Laboratories, Inc. Stoppering method to maintain sterility
US6566144B1 (en) 2000-03-27 2003-05-20 Atrix Laboratories Cover plate for use in lyophilization
US8283135B2 (en) 2000-06-30 2012-10-09 The Procter & Gamble Company Oral care compositions containing combinations of anti-bacterial and host-response modulating agents
ATE401089T1 (de) * 2000-06-30 2008-08-15 Procter & Gamble Orale zubereitungen, die antimikrobielle wirkstoffe enthalten zur prävention von systemischen erkrankungen
ES2309076T3 (es) 2000-06-30 2008-12-16 THE PROCTER & GAMBLE COMPANY Composiciones orales que comprenden un agente modulador de la respuesta del huesped.
US8470359B2 (en) 2000-11-13 2013-06-25 Qlt Usa, Inc. Sustained release polymer
US20030152637A1 (en) * 2001-01-25 2003-08-14 Mark Chasin Local anesthetic, and method of use
JP2003231622A (ja) * 2001-12-04 2003-08-19 Kao Corp 口腔用組成物
CN102266272B (zh) 2002-11-27 2012-12-26 Dmi生物科学公司 一种个人护理组合物及其产品
JP2007506767A (ja) * 2003-09-25 2007-03-22 ディーエムアイ バイオサイエンシズ インコーポレイテッド Ｎ−アシル−ｌ−アスパラギン酸を利用した方法および製造物
US20050084551A1 (en) 2003-09-26 2005-04-21 Jensen Claude J. Morinda citrifolia-based oral care compositions and methods
US20050125015A1 (en) * 2003-12-04 2005-06-09 Mcnally-Heintzelman Karen M. Tissue-handling apparatus, system and method
US20050125033A1 (en) * 2003-12-04 2005-06-09 Mcnally-Heintzelman Karen M. Wound closure apparatus
PL1776109T3 (pl) * 2004-08-13 2009-06-30 Schering Plough Ltd Farmaceutyczna formulacja zawierająca antybiotyk, triazol i kortykosteroid
EP1791791B1 (en) * 2004-09-27 2019-05-29 Special Water Patents B.V. Methods and compositions for treatment of water
WO2007099398A2 (en) 2005-09-27 2007-09-07 Naturalite Benelux B.V. Methods and compositions for treatment of skin
US7611494B2 (en) * 2005-02-08 2009-11-03 Confluent Surgical, Inc. Spray for fluent materials
WO2007016310A2 (en) * 2005-07-28 2007-02-08 Indiana University Research & Technology Corporation Niobium oxide compositions, nanostructures, bioactive forms and uses thereof
US20070178220A1 (en) * 2006-01-31 2007-08-02 Karlinsey Robert L Materials and methods for manufacturing amorphous tricalcium phosphate and metal oxide alloys of amorphous tricalcium phosphate and methods of using the same
ES2427161T5 (es) 2006-11-13 2018-01-22 The Procter & Gamble Company Productos y métodos para revelar afecciones en la cavidad oral
US8298516B2 (en) * 2006-12-22 2012-10-30 Douglas Anderson Calculus dissolving dental composition and methods for using same
US20090088723A1 (en) * 2007-09-28 2009-04-02 Accessclosure, Inc. Apparatus and methods for treating pseudoaneurysms
CN102065752A (zh) * 2008-05-02 2011-05-18 宝洁公司 用于显示口腔中的病症的产品及方法
PL2349490T3 (pl) 2008-11-25 2015-01-30 Procter & Gamble Kompozycja wybielająca z topioną krzemionką
CA2750242C (en) 2009-02-12 2018-05-22 Incept, Llc Drug delivery through hydrogel plugs
US20120065221A1 (en) 2009-02-26 2012-03-15 Theraquest Biosciences, Inc. Extended Release Oral Pharmaceutical Compositions of 3-Hydroxy-N-Methylmorphinan and Method of Use
US8980229B2 (en) 2009-04-01 2015-03-17 Colgate-Palmolive Company Dentifrice compositions and methods for treating and preventing damage to tooth surfaces
US8434489B2 (en) 2009-10-23 2013-05-07 Conceptus, Inc. Contraceptive devices and methods
US20110104080A1 (en) 2009-11-03 2011-05-05 David Salloum Salloum Oral Compositions for Treatment of Dry Mouth
US20110104081A1 (en) 2009-11-03 2011-05-05 Douglas Craig Scott Oral Compositions for Treatment of Dry Mouth
ES2701018T3 (es) 2010-04-01 2019-02-20 Procter & Gamble Control del mal olor de toda la boca mediante una combinación de agentes antibacterianos y desodorantes
RU2012158245A (ru) 2010-07-19 2014-08-27 Дзе Проктер Энд Гэмбл Компани Композиции, содержащие производные эфирно-масличных соединений, и их применение в средствах личной гигиены
US20120076734A1 (en) * 2010-09-15 2012-03-29 Jacob Olson Radiopaque antibiotic dental paste and uses thereof
US8900557B2 (en) 2010-12-30 2014-12-02 Jr Chem, Llc Dental cleaning composition
US10226417B2 (en) 2011-09-16 2019-03-12 Peter Jarrett Drug delivery systems and applications
WO2013086015A1 (en) 2011-12-05 2013-06-13 Incept, Llc Medical organogel processes and compositions
US20130344120A1 (en) 2012-06-21 2013-12-26 Douglas Craig Scott Mouth Rinse Emulsions
US10123953B2 (en) 2012-06-21 2018-11-13 The Procter & Gamble Company Reduction of tooth staining derived from cationic antimicrobials
BR112015010146A2 (pt) 2012-11-05 2017-07-11 Procter & Gamble sílica precipitada tratada com calor
US9827082B2 (en) 2013-02-26 2017-11-28 Orthoaccel Technologies, Inc. Fluoride releasing bite plate
BR112015024772A2 (pt) 2013-04-10 2017-07-18 Procter & Gamble composições para tratamento bucal contendo partículas de poli-organossilsesquioxano
CN105101945A (zh) 2013-04-10 2015-11-25 宝洁公司 包含聚有机倍半硅氧烷颗粒的口腔护理组合物
RU2015141323A (ru) 2013-04-10 2017-05-11 Дзе Проктер Энд Гэмбл Компани Композиции для ухода за полостью рта, содержащие частицы полиорганосилсесквиоксана
US9572212B2 (en) 2014-05-21 2017-02-14 Lumens Co., Ltd. LED lighting device using AC power supply
EP3331491B1 (en) 2015-08-04 2022-03-23 ISP Investments LLC Polymers derived from amino-functional vinyl alcohol ethers and applications thereof
ES2989135T3 (es) 2015-12-15 2024-11-25 John A Gontarz Formulación para el cuidado bucal y método para la eliminación del sarro y la placa de los dientes
WO2019121660A1 (en) 2017-12-20 2019-06-27 Firmenich Sa Oral care compositions
JP7487100B2 (ja) 2017-12-21 2024-05-20 フイルメニツヒ ソシエテ アノニム 清涼および風味増強組成物
US11191709B2 (en) 2019-04-26 2021-12-07 The Procter & Gamble Company Reduction of tooth staining derived from cationic antimicrobials
WO2021102896A1 (en) 2019-11-29 2021-06-03 Givaudan Sa Organic compounds
WO2021174475A1 (en) 2020-03-05 2021-09-10 Givaudan Sa Organic compounds
GB202012170D0 (en) 2020-08-05 2020-09-16 Givaudan Sa Organic compounds
WO2022170519A1 (en) 2021-02-09 2022-08-18 Givaudan Sa Organic compounds
GB202105661D0 (en) 2021-04-21 2021-06-02 Givaudan Sa Organic compounds
GB202303792D0 (en) 2023-03-15 2023-04-26 Givaudan Sa Cosmetic composition

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3608057A (en) * 1967-10-03 1971-09-21 Amicon Corp Process for making contact lenses
US4017615A (en) * 1970-10-29 1977-04-12 Syntex Corporation Propylene carbonate ointment vehicle
US3867190A (en) * 1971-10-18 1975-02-18 American Cyanamid Co Reducing capillarity of polyglycolic acid sutures
US3736646A (en) * 1971-10-18 1973-06-05 American Cyanamid Co Method of attaching surgical needles to multifilament polyglycolic acid absorbable sutures
US4048256A (en) * 1976-06-01 1977-09-13 American Cyanamid Company Normally-solid, bioabsorbable, hydrolyzable, polymeric reaction product
US4328204A (en) * 1977-03-02 1982-05-04 Ethicon, Inc. Absorbable polymer-drug compounds and method for making same
US4293539A (en) * 1979-09-12 1981-10-06 Eli Lilly And Company Controlled release formulations and method of treatment
US4454110A (en) * 1982-05-24 1984-06-12 Forsyth Dental Infirmary For Children Self-gelling liquid composition for topical application in the oral cavity
US4443430A (en) * 1982-11-16 1984-04-17 Ethicon, Inc. Synthetic absorbable hemostatic agent
US4685883A (en) * 1983-09-12 1987-08-11 Jernberg Gary R Local delivery of chemotherapeutic agents for the treatment of periodontal disease
GR80494B (en) * 1983-10-07 1985-02-04 Forsyth Dental Infirmary Intra-pocket drug delivery devices for treatment of periodontal diseases
JPS60100516A (ja) * 1983-11-04 1985-06-04 Takeda Chem Ind Ltd 徐放型マイクロカプセルの製造法
US4650665A (en) * 1985-02-08 1987-03-17 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4568536A (en) * 1985-02-08 1986-02-04 Ethicon, Inc. Controlled release of pharmacologically active agents from an absorbable biologically compatible putty-like composition
US4670252A (en) * 1985-05-24 1987-06-02 The Procter & Gamble Company Treatment of oral diseases
US4624256A (en) * 1985-09-11 1986-11-25 Pfizer Hospital Products Group, Inc. Caprolactone polymers for suture coating
JPS62223112A (ja) * 1986-03-25 1987-10-01 Rooto Seiyaku Kk 歯周病治療剤
US4780320A (en) * 1986-04-29 1988-10-25 Pharmetrix Corp. Controlled release drug delivery system for the periodontal pocket
US4713243A (en) * 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
US4758435A (en) * 1986-08-11 1988-07-19 American Cyanamid Company Estradiol implant composition and method for preparation
JPH0617300B2 (ja) * 1986-09-22 1994-03-09 サンスタ−株式会社 歯周疾患治療用組成物
DE3708916A1 (de) * 1987-03-19 1988-09-29 Boehringer Ingelheim Kg Verfahren zur reinigung resorbierbarer polyester
JPH0645535B2 (ja) * 1987-05-20 1994-06-15 サンスタ−株式会社 歯槽骨代謝治療用組成物
IL86802A0 (en) * 1987-06-30 1988-11-30 Vipont Pharma Drug delivery devices
US5005074A (en) * 1989-11-17 1991-04-02 Rca Licensing Corporation Adaptive multistandard video comb filter
US5262164A (en) * 1989-11-17 1993-11-16 The Procter & Gamble Company Sustained release compositions for treating periodontal disease

Also Published As

Publication number Publication date
NZ236113A (en) 1993-05-26
DE69016755T2 (de) 1995-09-21
JPH03271219A (ja) 1991-12-03
AU648278B2 (en) 1994-04-21
JP3051154B2 (ja) 2000-06-12
CA2029046A1 (en) 1991-05-18
IE66371B1 (en) 1995-12-27
US5198220A (en) 1993-03-30
CA2029046C (en) 1995-03-28
GR3015027T3 (en) 1995-05-31
KR910009243A (ko) 1991-06-28
ATE118170T1 (de) 1995-02-15
FI905683L (fi) 1991-05-18
ES2067696T3 (es) 1995-04-01
IE904147A1 (en) 1991-05-22
AU6667690A (en) 1991-05-23
FI98126B (fi) 1997-01-15
EP0430474B1 (en) 1995-02-08
EP0430474A1 (en) 1991-06-05
FI98126C (fi) 1997-04-25
KR0156917B1 (ko) 1998-11-16
DE69016755D1 (de) 1995-03-23
DK0430474T3 (da) 1995-04-03

Similar Documents

Publication Publication Date Title
FI98126B (fi) Menetelmä hidastetusti vapauttavan koostumuksen valmistamiseksi
FI98124B (fi) Menetelmä hidastetusti vapauttavien koostumusten valmistamiseksi
ES2099977T5 (es) Composiciones de liberacion prolongada para tratar enfermedades periodontales.
FI98125B (fi) Menetelmä hidastetusti vapauttavien koostumusten valmistamiseksi
ES2044925T3 (es) Composiciones farmaceuticas de liberacion retardada.
FI884636A0 (fi) Pitkävaikutteisen farmaseuttisen valmisteen valmistusmenetelmä
DE68915132D1 (de) Verfahren zur Behandlung von Periodontitis durch protrahierte Wirkstoffabgabe von Arzneimitteln in der Zahnhöhle, Zusammensetzung davon und Vorrichtung zur Verabreichung.
NO951630D0 (no) Fremgangsmåte for administrering av azithromycin
JPS57150609A (en) Pharmaceutical composition, heterogeneous copolymer comprising lactic acid and glycolic acid units and manufacture
ATE148340T1 (de) Naproxen-tabletten mit gesteuerter wirkstoffabgabe
YU196488A (en) Process for obtaining oral formulation for controlled and extended releasing of bispirone and its salts

Legal Events

Date Code Title Description
BB Publication of examined application
FG Patent granted

Owner name: THE PROCTER & GAMBLE COMPANY